Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?

• Miriam Kelm,
• Franziska Darzentas,
• Nikos Darzentas,
• Michaela Kotrova,
• Wiebke Wessels,
• Sonja Bendig,
• Claudia D. Baldus,
• Marcus Lettau,
• Nicola Gökbuget,
• Dieter Kabelitz,
• Monika Brüggemann,
• Guranda Chitadze

Affiliations

Miriam Kelm

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Franziska Darzentas

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Nikos Darzentas

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Michaela Kotrova

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Wiebke Wessels

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Sonja Bendig

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Claudia D. Baldus

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Marcus Lettau

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Nicola Gökbuget

4 Department of Medicine II, Goethe University Hospital, Frankfurt, Germany

Dieter Kabelitz

3 Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Monika Brüggemann

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany

Guranda Chitadze

1 Medical Department II, Hematology and Oncology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein, Germany